Analyst
Cantor
Equibles does not estimate personal net worth.
Steve Seathouse is recorded as Analyst at Cantor. Steve Seathouse has spoken on 1 earnings call across 1 company, most recently for Biocryst Pharmaceuticals Inc on November 4, 2026. The companies whose calls Steve Seathouse spoke on are classified in the Healthcare sector.
“Sort of related to the long-term revenue projections, but specifically as it pertains to Orlodeo and just the stickiness of that, have you guys done any updated market research post the Ducryctoband prophylaxis phase 3 result, and do you have a sense that that was above, below, or sort of in line with expectations of…”
Cantor
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
